SQZ Biotechs Cancer Candidate Shows Response At Low Dose In HPV16 Solid Tumor Patient
SQZDelisted Stock | USD 0.10 0.04 28.57% |
Slightly above 62% of Sqz Biotechnologies' investor base is looking to short. The analysis of current outlook of investing in Sqz Biotechnologies Co suggests that many traders are alarmed regarding Sqz Biotechnologies' prospects. Sqz Biotechnologies' investing sentiment can be driven by a variety of factors including economic data, Sqz Biotechnologies' earnings reports, geopolitical events, and overall market trends.
Sqz |
SQZ Biotechnologies Company announced that a confirmed complete response was observed in the first patient in the lowest-dose cohort of the Phase 1 SQZ-AAC-HPV-101 trial. The second and third patients have also been enrolled in the trial. The company has completed the dose-limiting toxicity period for the lowest-dose cohort. The Study Safety Committee has completed its review and recommends that the company enroll patients in the highest dose cohort. The company anticipates initial c
Read at finance.yahoo.com
Sqz Biotechnologies Fundamental Analysis
We analyze Sqz Biotechnologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sqz Biotechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sqz Biotechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Sqz Biotechnologies is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Sqz Biotechnologies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sqz Biotechnologies stock to make a market-neutral strategy. Peer analysis of Sqz Biotechnologies could also be used in its relative valuation, which is a method of valuing Sqz Biotechnologies by comparing valuation metrics with similar companies.
Peers
Sqz Biotechnologies Related Equities
ANTX | AN2 Therapeutics | 21.90 | ||||
PCSA | Processa Pharmaceuticals | 18.37 | ||||
MNPR | Monopar Therapeutics | 8.84 | ||||
IKT | Inhibikase Therapeutics | 6.96 | ||||
LIPO | Lipella Pharmaceuticals | 5.42 | ||||
QNRX | Quoin Pharmaceuticals | 1.69 | ||||
HOWL | Werewolf Therapeutics | 1.52 | ||||
PMVP | Pmv Pharmaceuticals | 1.25 | ||||
KZR | Kezar Life | 0.95 | ||||
SNTI | Senti Biosciences | 0.93 | ||||
FENC | Fennec Pharmaceuticals | 0.83 | ||||
ANEB | Anebulo Pharmaceuticals | 0.70 | ||||
NUVB | Nuvation Bio | 0.35 | ||||
SABS | SAB Biotherapeutics | 1.02 | ||||
THRD | Third Harmonic | 2.67 | ||||
CADL | Candel Therapeutics | 4.85 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Sqz Stock
If you are still planning to invest in Sqz Biotechnologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sqz Biotechnologies' history and understand the potential risks before investing.
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |